Estrella Immunopharma, Inc. Share Price
ESLAEstrella Immunopharma, Inc. Stock Performance
Open $1.52 | Prev. Close $1.70 | Circuit Range N/A |
Day Range $1.52 - $1.52 | Year Range $0.78 - $3.08 | Volume 198 |
Average Traded $1.52 |
Estrella Immunopharma, Inc. Share Price Chart
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
Estrella Immunopharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $1.52 | $1.63 | +0.00% |
30-Apr-26 | $1.52 | $1.63 | -4.41% |
27-Apr-26 | $1.65 | $1.70 | +8.63% |
24-Apr-26 | $1.71 | $1.56 | -16.53% |
17-Apr-26 | $1.90 | $1.88 | +11.61% |
16-Apr-26 | $1.67 | $1.68 | -2.89% |
15-Apr-26 | $1.64 | $1.73 | -4.95% |
FAQs on Estrella Immunopharma, Inc. Share Price
Can I buy Estrella Immunopharma, Inc. shares in India?
What is the share price of Estrella Immunopharma, Inc.?
What is the 5 year returns of Estrella Immunopharma, Inc.?
What are the high & low stock price of Estrella Immunopharma, Inc. today?
What is the 52-week high and low of Estrella Immunopharma, Inc. stock?